Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Nahlsgen is an inhibitor of γ-glutamyl transpeptidase (GGT; Ki = 170 µM).1 It increases left ventricular developed pressure (LVDP), decreases left ventricular end-diastolic pressure (LVEDP), and reduces left ventricle homogenate malondialdehyde (MDA), coronary perfusate norepinephrine, and cardiac oxygen radical levels in perfused isolated rat hearts in a model of ischemia-reperfusion injury when used at a concentration of 1 µM.2 Nahlsgen (5 mg/kg) inhibits IL-13-induced airway constriction in a mouse model of allergic asthma.3 Formulations containing nahlsgen have been used in cosmetics and creams.
WARNING This product is not for human or veterinary use.
1. Design, synthesis, and evaluation of γ-
2. Involvement of γ-
3. Inhibiting lung lining fluid glutathione metabolism with GGsTop as a novel treatment for asthma. Front. Pharmacol. 5, 179 (2014).